F. Amalric et al., EXPRESSION OF HUMAN FIBROBLAST GROWTH FACTOR-II AND CELL-TRANSFORMATION - SOME PARADOXICAL ASPECTS, Antibody immunoconjugates, and radiopharmaceuticals, 8(4), 1995, pp. 243-250
Citations number
24
Categorie Soggetti
Immunology,"Radiology,Nuclear Medicine & Medical Imaging
Human fibroblast growth factor 2 (FGF-2) is involved in various physio
logical processes including developpement, wound healing, angiogenesis
and malignant transformation. FGF-2 is expressed as four isoforms res
ulting from alternative initiations of translation on the same mRNA, a
t three CUG and one AUG start codons. These FGF-2 isoforms have distin
ct intracellular localizations and can modify cell phenotype different
ly. We have previously shown that FGF-2 expression of the nuclear loca
lized CUGs initated forms led to immortalization of transfected cells
when the cytoplasmic AUG initiated form transformed the same cells. He
re we have analysed FGF-2 expression in various human cells by Western
immunoblotting: different profiles of the four isoforms were observed
, depending on the cell types. The CUG-initiated forms were mainly det
ected in transformed cell lines but not in normal cell types that most
ly overproduced the AUG initiated form. To understand the role of thes
e different forms we have established HeLa and skin fibroblasts (SE) c
ell lines constitutively expressing one or the other form. Surprisingl
y the constitutive expression of the 18 kDa AUG initiated form inhibit
ed the anchorage independent growth of HeLa transfected cells whereas
it allowed colonies formation in soft agar of SF modified cells. We di
scuss here the possibility that the oncogenic potential of FGF-2 lies
in a physiological balance between the different isoforms.